Nordea Investment Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-45,500
| Closed | -$2.25M | – | 1024 |
|
|
2017
Q2 | $2.25M | Sell |
45,500
-30,587
| -40% | -$1.51M | 0.01% | 540 |
|
|
2017
Q1 | $3.31M | Buy |
76,087
+7,337
| +11% | +$319K | 0.01% | 475 |
|
|
2016
Q4 | $3.37M | Buy |
68,750
+519
| +0.8% | +$25.4K | 0.01% | 431 |
|
|
2016
Q3 | $3.27M | Buy |
68,231
+23,831
| +54% | +$1.14M | 0.01% | 396 |
|
|
2016
Q2 | $2.38M | Sell |
44,400
-1,000
| -2% | -$53.6K | 0.01% | 388 |
|
|
2016
Q1 | $2.03M | Sell |
45,400
-2,000
| -4% | -$89.4K | 0.01% | 404 |
|
|
2015
Q4 | $1.81M | Buy |
47,400
+8,900
| +23% | +$340K | 0.01% | 427 |
|
|
2015
Q3 | $1.23M | Buy |
38,500
+12,700
| +49% | +$404K | ﹤0.01% | 416 |
|
|
2015
Q2 | $852K | Buy |
25,800
+13,900
| +117% | +$459K | ﹤0.01% | 478 |
|
|
2015
Q1 | $490K | Buy |
11,900
+1,000
| +9% | +$41.2K | ﹤0.01% | 577 |
|
|
2014
Q4 | $444K | Buy |
+10,900
| New | +$444K | ﹤0.01% | 595 |
|